Insulet Corporation (PODD)

NASDAQ

$140.74

$-1.31

(-0.93%)

Pre-Market

Insulet Corporation (PODD) Live Price Chart

Last updated: ⁦2026-10-20 11:32:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Insulet Corporation (PODD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $140.74, with a market capitalization of $9.79B and a P/E ratio of 26.23. Over the past 52 weeks, its price has ranged from $126.40 to $354.88. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$9.79B
Open	$142.05
Day's High	$354.88
Day's Low	$2.57
Previous Close	$141.96
Volume	574.00
Average Volume	1.71M
P/E Ratio	26.23
52-Week High	$354.88
52-Week Low	$126.40
Dividend Yield	--
Earnings Date	--

Insulet Corporation (PODD) Pre-Market Stock Price

Insulet Corporation (PODD) is trading at $140.74 in pre-market trading as of 2026-10-20 11:24:00, down 0.86% ($1.22) from the previous close of $141.96

Pre-market trading shows how investors are pricing PODD before the regular session opens. The current pre-market price is below the previous close, indicating cautious early trading sentiment.

Insulet Corporation (PODD) 7-Day Stock Price Change

Over the past seven days, Insulet Corporation (PODD) moved from $135.28 to $140.74, representing a gain of 4.03% ($5.46).

The stock traded between $133.58 and $143.31 during the period. The latest price is near the upper end of the 7-day range, indicating moderate upward.

The average daily volume was 1.63 million shares, down versus the previous seven-day period, indicating lower trading activity.

PODD 52-Week Price Position

Position in Range: 6.3%

52W Low$126.40

52W High$354.88

PODD is currently trading at $140.74, placing it 6.3% of the way from its 52-week low of $126.40 to its 52-week high of $354.88. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Insulet Corporation (PODD)?

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.

Insulet Corporation Information

Industry	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Employees	5400
Exchange	NASDAQ
Company Website	https://www.insulet.com

How to Buy Insulet Corporation (PODD) Stock on MEXC

Eligible investors can buy real shares of Insulet Corporation (PODD) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for PODD and Place Your Order

Open the RealStocks trading page and search for PODD. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Insulet Corporation (PODD) stock price today?

Insulet Corporation (PODD) is currently trading at $ 140.74, down 0.86% ($1.22) from the previous close of $ 141.96. Intraday prices update in real time during regular trading hours.

2.Is PODD stock going up or down today?

As of 2026-10-20 11:24:00, PODD is trading at $ 140.74, down 0.86% ($1.22) from its previous close of $ 141.96. The stock has traded between $ 2.57 and $ 354.88 during today’s regular session. Past price movements do not guarantee future results.

3.What is PODD pre-market price?

As of 2026-10-20 11:24:00, PODD is trading at $ 140.74 in pre-market trading, down 0.86% ($1.22) from the previous close of $ 141.96. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is PODD after-hours price?

As of 2026-10-20 11:24:00, PODD is trading at $ 142.05 in after-hours trading, up 0.06% ($0.09) from the regular-session close of $ 141.96. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is PODD stock trading now?

PODD trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does PODD sit relative to its 52-week high and low?

Over the past 52 weeks, PODD has traded between a low of $ 126.40 and a high of $ 354.88. At $ 140.74, the stock is positioned 6.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Insulet Corporation in?

Insulet Corporation (PODD) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Insulet Corporation's market capitalization and where is it listed?

Insulet Corporation is listed on the NASDAQ exchange with a market capitalization of $ 9.79B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is PODD valued in terms of P/E ratio and EPS?

PODD trades at a P/E ratio of 26.23, based on trailing-twelve-month EPS of $ 5.41. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Insulet Corporation pay a dividend?

Insulet Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.